1. Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
   Gabriela Schneider et al, 2014, Molecular Cancer Research CrossRef
2. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications
   AGATA PONIEWIERSKA-BARAN et al, 2015, International Journal of Oncology CrossRef
3. MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development
   Maciej Cieśla et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
4. Trichostatin A Inhibits Rhabdomyosarcoma Proliferation and Induces Differentiation through MyomiR Reactivation
   Maciej Tarnowski et al, 2019, Folia Biologica CrossRef
5. DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist
   Leonidas Benetatos et al, 2014, Cellular and Molecular Life Sciences CrossRef
6. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? – Studies with the NTera2 Cell Line
   Zachariah P. Sellers et al, 2017, Stem Cell Reviews and Reports CrossRef
7. Analysis of the Paternally-Imprinted DLK1–MEG3 and IGF2–H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target
   Zachariah Payne Sellers et al, 2018, Stem Cell Reviews and Reports CrossRef
8. Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications
   AGATA PONIEWIERSKA-BARAN et al, 2016, International Journal of Oncology CrossRef
9. Size-based detection of sarcoma circulating tumor cells and cell clusters
   Masanori Hayashi et al, 2017, Oncotarget CrossRef
10. Effects of paternal exposure to cigarette smoke on sperm DNA methylation and long-term metabolic syndrome in offspring
    Yunyun Liu et al, 2022, Epigenetics & Chromatin CrossRef
11. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database
    Zichao Zhang et al, 2017, Gene CrossRef
12. 5-Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin-like growth factor 2 expression and reactivating the H19 gene product miR-675, which negatively affects insulin-like growth factors and insulin signaling
    MACIEJ TARNOWSKI et al, 2015, International Journal of Oncology CrossRef